Patrick Cox's Tech Digest - View by Tag "biotech"

Early Bottlenecks in Developing Biopharmaceutical Products Delay Commercialization

August 21, 2014

National Institutes of Health (NIH) has published a study in the journal Science Translational Medicine to show how “bottlenecking” pharmaceutical companies early in the drug development slows down the process immensely of getting a drug to market. One of the phenomena observed was that companies often run into so much red tape in the development pathway that they are forced to give up on a product. They normally then sell that technology to another firm to repurpose the technology into another product. This study represents further proof that our current drug development regulations are counterproductive.

Apple’s Smartwatch May put Biotech on Silicon Valley Time

September 10, 2014

Tech sites are buzzing right now about the new Apple smartwatch and iPhone. Having been a part of or close to the tech industry for a long time, the excitement that builds over new products doesn’t normally move me much. This time, though, it’s a little different because of reports that the phone and watch will be integrated to support healthcare apps.

Changing the Odds at the Big Casino

May 1, 2015

I remember a public service announcement (PSA), probably by the American Cancer Society, that aired on television when I was three or four. I clearly recall a picture on screen of five people sitting around a dinner table. The picture was starkly black and white, and a voiceover announced grimly, “One in five people will die of cancer.”

The Regulatory Transformation Begins

June 12, 2015

This issue isn’t going to be what I had planned it to be. Our household is in upheaval right now because an older relative just slipped hard down the slope of cognitive decline. My wife has experienced a truly unpleasant role reversal, taking the car keys away from her father following a couple of scary events. Routes that he’s driven for decades now baffle him. He’s been lost several times and recently had an accident.

Why Treating Age as a Disease Will Save Our Failing Healthcare System

July 2, 2015

A couple of weeks ago, I wrote in an article for the TransTech Digest about a potentially transformative meeting that has presumably already taken place. If things went as planned, a group of researchers that included Dr. Nir Barzilai of the Albert Einstein College of Medicine (AICM) met with the FDA to explore the possibility of moving anti-diabetes drug Metformin into clinical trials for life extension.

Deep-Purple Mesoamerican Corn and Nutrition Puzzles

July 10, 2015

Whenever I give a speech, I include the fact that all transformational biotech breakthroughs have been initially rejected by the medical establishment. There’s a section about this in my forthcoming book as well. I do this simply to disabuse people of the notion that scientific progress is welcomed. In fact, nearly all truly important biotechnologies and those who discover them are rejected and treated as pariahs before being accepted.

Move Over, Skynet—Brainet’s in Town

July 17, 2015

About once a week, I get a call from someone with a strong East Asian accent named Martha or Ralph or something else traditionally American. They tell me that they are calling from the “Microsoft Service Center” or “your computer service contract provider” because my computer is generating error messages, which they would like to help me fix.

mHealth, Genomics, and Interracial Marriage

September 4, 2015

In my digest piece last week, I included a video presentation by Dr. Eric Topol, the cardiologist, geneticist, researcher, and writer who serves as director of the Scripps Translational Science Institute in La Jolla, California. Topol is predicting rapid and radical change in the ways that healthcare is delivered; I’m currently reading his new book, The Patient Will See You Now: The Future of Medicine Is in Your Hands.

China’s Meltdown: Dangers and Opportunities

September 11, 2015

The buzz around Mauldin Economics’ virtual water cooler these days is El Jefe’s new documentary, China on the Edge. The timing for the online release, September 23, is propitious given the media attention to the meltdown of the Chinese market. The list of participants is impressive, and John has spent considerable time over the last few years wrapping his brain around the staggering number of variables at play in the People’s Republic of China.

Mobile Health Apps Will Solve Critical Nutritional Puzzles and Enable Effective Anti-Aging Diets

October 2, 2015

You probably didn’t notice when it happened, but smartphone health apps have made their way, for the first time, into the clinic. Over the last six months or so, a mobile Health (mHealth) app has been integrated into the practices of doctors associated with a major medical university. Whether you know it or not, this will change your life.

Welcome to the “Age” Age

October 16, 2015

John Mauldin and I spent the day at “the Buck” earlier this week at the invitation of Brian K. Kennedy, PhD, the president and CEO of the Buck Institute for Research on Aging. The Buck is the world’s first major scientific research institution dedicated to solving the problems of aging. This includes, to make things clear, the development of anti-aging biotechnologies. Founded in 1999, the institute currently employs about 140 PhDs as well as more than 100 technicians and support staff in 22 labs dedicated to different challenges.

Falling Birth Rates, the Immigration Crisis, and Biotech

January 29, 2016

For months now, the topic of immigration has dominated the news. Limits on immigration appear to be the central issue in upcoming elections across the Western world. While the movement of people between nations has obvious demographic consequences, there are less obvious and deeper demographic issues at the heart of the arguments between those who want more or less immigration.

AI Will Help Us Find the Key to Immortality

July 11, 2016

The field of anti-aging medicine has finally entered the mainstream. It’s no longer controversial for scientists to talk about extending health spans by delaying the systems failures that spawn age-related disease. In fact, we’ve made great strides in identifying methods that will allow people to live closer to their approximately 120-year maximum life spans.

Page 1 of 2.  1 2 > 

Stay Up to Date!

Simply enter your email below and click SIGN UP!

112 Years Old ... Still The Life of the Party - Find out more here

« Back to all articles

112 Years Old ... Still The Life of the Party - Find out more here